SATLIV-300 tablets contain Ursodeoxycholic Acid (UDCA), used to treat gallstones and primary biliary cirrhosis. UDCA works by reducing cholesterol production and dissolving cholesterol-based gallstones, improving bile flow in liver disease. It helps protect liver cells and improve liver function. Dosage and duration should be determined by a healthcare provider to ensure effective treatment and minimize potential side effects in managing gallstone and liver conditions.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations